CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 159 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $56,000 | -76.8% | 14,928 | 0.0% | 0.00% | – |
Q4 2015 | $241,000 | +53.5% | 14,928 | 0.0% | 0.00% | – |
Q3 2015 | $157,000 | -72.2% | 14,928 | -33.3% | 0.00% | -100.0% |
Q2 2015 | $564,000 | +171.2% | 22,392 | +200.0% | 0.00% | – |
Q1 2015 | $208,000 | -75.4% | 7,464 | -83.9% | 0.00% | -100.0% |
Q4 2014 | $844,000 | +770.1% | 46,423 | +522.0% | 0.00% | – |
Q3 2014 | $97,000 | -65.6% | 7,464 | -65.2% | 0.00% | – |
Q2 2014 | $282,000 | -42.1% | 21,450 | -35.7% | 0.00% | -100.0% |
Q1 2014 | $487,000 | -90.8% | 33,359 | -83.7% | 0.00% | -90.0% |
Q4 2013 | $5,299,000 | -7.6% | 204,238 | +26.2% | 0.01% | 0.0% |
Q3 2013 | $5,736,000 | +60.3% | 161,893 | -29.4% | 0.01% | +42.9% |
Q2 2013 | $3,578,000 | – | 229,182 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |